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A shape-shifting redox foldase contributes
to Proteus mirabilis copper resistance
Emily J. Furlong1, Alvin W. Lo2,3, Fabian Kurth1,w, Lakshmanane Premkumar1,2,w, Makrina Totsika2,3,w,
Maud E.S. Achard2,3,w, Maria A. Halili1, Begon˜a Heras4, Andrew E. Whitten1,w, Hassanul G. Choudhury1,w,
Mark A. Schembri2,3 & Jennifer L. Martin1,5
Copper resistance is a key virulence trait of the uropathogen Proteus mirabilis. Here we show
that P. mirabilis ScsC (PmScsC) contributes to this defence mechanism by enabling swarming
in the presence of copper. We also demonstrate that PmScsC is a thioredoxin-like disulfide
isomerase but, unlike other characterized proteins in this family, it is trimeric. PmScsC
trimerization and its active site cysteine are required for wild-type swarming activity in the
presence of copper. Moreover, PmScsC exhibits unprecedented motion as a consequence of a
shape-shifting motif linking the catalytic and trimerization domains. The linker accesses
strand, loop and helical conformations enabling the sampling of an enormous folding land-
scape by the catalytic domains. Mutation of the shape-shifting motif abolishes disulfide
isomerase activity, as does removal of the trimerization domain, showing that both features
are essential to foldase function. More broadly, the shape-shifter peptide has the potential for
‘plug and play’ application in protein engineering.
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T
he Escherichia coli periplasmic Dsb protein family is the
best characterized bacterial oxidative folding system. E coli
DsbA is a monomeric thioredoxin-fold oxidase1 that
introduces disulfide bonds into protein substrates2, whereas
E. coli DsbC is a dimeric V-shaped thioredoxin-fold protein
disulfide isomerase3 that proof-reads and shuffles incorrect
disulfide bonds4. E. coli DsbG is also a dimeric V-shaped
thioredoxin-fold protein disulfide isomerase and cysteine
reducing system5 that protects cysteines of periplasmic proteins
from inappropriate oxidation6.
Here, we characterize a putative DsbA-like protein from
P. mirabilis and show it plays a key role in virulence by enabling
swarming during copper stress. We find that it is not DsbA-like,
as it does not catalyse disulfide bond formation. Rather, it is a
disulfide isomerase that shuffles incorrect disulfide bonds in
proteins. Further, we show that this thioredoxin fold protein is
unlike any other characterized to date—it is trimeric—and we
demonstrate that its function depends on a shape-shifting motif
that could potentially be used as a ‘plug and play’ peptide module.
Results
Proteus mirabilis UniProt C2LPE2 is a predicted thioredoxin-fold
protein, and the purified protein exhibits redox properties
characteristic of the thioredoxin fold family. It is highly oxidizing
( 108mV), has an acidic active site cysteine (pKa 3.1; compared
to a typical cysteine thiol pKa ofB8–9) and the oxidized disulfide
form of the active site destabilizes the protein compared with the
reduced form (Supplementary Fig. 1a–c).
The encoded protein plays an important role in P. mirabilis
virulence. Copper intoxication is a component of nutritional
immunity having a number of detrimental effects on bacterial
cells. Copper can react with host-generated hydrogen peroxide to
generate free radicals, which damage biological molecules7;
cycling between Cu(I) and Cu(II) can lead to detrimental redox
reactions in bacteria; and copper can bind to protein thiols in
place of other metal co-factors8,9. Overcoming these antibacterial
effects of copper is a key bacterial defence mechanism. The gene
encoding P. mirabilis C2LPE2 is located within a cluster of four
predicted suppressor of copper sensitivity (Scs) genes and we
proposed this the encoded protein (hereafter called PmScsC)
would contribute to bacterial copper resistance. Indeed,
inactivation of scsC in two independent P. mirabilis clinical
isolates significantly inhibited swarming motility (a key virulence
trait of P. mirabilis) in the presence of copper (Fig. 1b,
Supplementary Figs 2–4). This phenotype could be
complemented by introduction of a plasmid encoding wild-type
PmScsC, but not a plasmid encoding an inactive PmScsC
(Fig. 1a,b).
Although it is annotated DsbA-like, PmScsC is a powerful
protein disulfide isomerase (Fig. 1c) that is able to refold and
reactivate the scrambled disulfide form of the model substrate
RNase A just as rapidly as the archetypal disulfide isomerase
E. coli DsbC. It has negligible DsbA-like dithiol oxidase activity
(Supplementary Fig. 1d).
The best-characterized protein disulfide isomerases—EcDsbC
and eukaryotic protein disulfide isomerase (PDI)—each have two
thioredoxin-fold catalytic domains. DsbC is a dimer, and PDI is a
modular 4-domain protein with two catalytically active thior-
edoxin domains. The presence of two thioredoxin catalytic
domains is thought to contribute to highly efficient disulfide
shuffling activity10,11. The amino acid sequence of PmScsC
encodes a single thioredoxin fold, and we therefore expected that
its disulfide isomerase activity would be a consequence of
dimerization to generate the necessary two catalytic domains.
We also expected that the protein would adopt the same dimeric
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Figure 1 | PmScsC function. (a) Linear representation of the domain
organization of PmScsC mutants. The trimerization domain is coloured
magenta, the catalytic domain is green, with the CXXC motif represented as
an orange circle, and the linker region is shown in cyan. The rigid helical
linker is shown in black. (b) Swarming motility of wild type P. mirabilis strain
PM54 (black), PmScsC deletion mutant PM54scsC (grey) and PM54scsC
containing control and complementation plasmids: PM54scsC(pSU2718)
(vector control; cyan), PM54scsC(pScsC) (wild-type; green), PM54scsC
(pScsC AXXC) (active site mutant; orange) and PM54scsC(pScsCDN) (N-
terminal trimerization domain deletion; magenta) in the presence of 1.5mM
CuSO4 on LB agar plates (significant difference, Po0.0001 for slope
calculated by F-test). Data are shown as the mean±s.d., of a single
experiment performed in triplicate; all data is representative of three
independent experiments. (c) Disulfide isomerase activity of PmScsC
(hollow squares) is similar to that of EcDsbC (filled circles). Monomeric
PmScsDN (filled squares) and the PmScsC mutant engineered to have a
rigid helical peptide (RHP) in place of the flexible peptide (filled diamonds)
show negligible activity (equivalent to oxidase EcDsbA (hollow circles)).
Data are shown as the mean±s.d., of two replicate experiments.
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architecture as V-shaped EcDsbC. However, we were wrong on
both counts.
Unexpectedly, evidence from chemical cross-linking
(Supplementary Fig. 5), small angle X-ray solution scattering
(Fig. 2a,b) and multi-angle light scattering (Fig. 2c) all indicated
that PmScsC is trimeric. We confirmed that PmScsC is a trimer
by determining three independent crystal structures. The three
crystal structures—which we refer to as compact, transitional and
extended (Fig. 3a–c, Table 1)—reveal an extraordinary range of
motion in this protein. Importantly, the compact and transitional
structures have multiple protomers in the asymmetric unit that
adopt the same overall structures in each case (8 compact trimers,
RMSDB1.5 Å for 645 Ca; two transitional trimers, RMSD 0.5Å
for 653 Ca) so that crystal symmetry does not appear to impact
on the observed conformation. Moreover, the compact and
transitional conformations were determined from crystals grown
under similar conditions (2.85M sodium malonate pH 5.8, 20 C
with either 0.1M cobalt or copper added). Nevertheless,
comparison of the eight compact and the two transitional trimers
in these two crystal structures, reveals an unprecedented level of
conformational re-arrangement (RMSDs420Å). The third
structure was determined from crystals grown in the presence
of 2mM copper chloride (32% Jeffamine M-600, 0.1M HEPES
pH 8, 20 C) and reveals a fully extended trimer with one
protomer in the asymmetric unit.
PmScsC also exhibits dynamic conformational flexibility in
solution. No single PmScsC crystal structure is consistent with the
experimentally determined SAXS scattering curve. However, an
ensemble of structures fits the experimental data closely
(Fig. 2a,b) supporting the notion that the trimer is highly
dynamic in solution. Moreover, the solution scattering curve is
unchanged by modification of the pH (range 6.0–8.0) or ionic
strength (150–1,500mM NaCl) (Supplementary Fig. 6) indicating
the dynamic motion is an inherent property of the protein.
We can pinpoint the region responsible for the extraordinary
range of motion in this protein, to an 11-residue peptide linking
the trimerization and catalytic domains (residues 39-KADEQ-
QAQFRQ-49) (Fig. 3). The 31 crystallographically characterized
PmScsC protomers have the same thioredoxin-fold catalytic
domains (Fig. 4a,b) (RMSD 0.2–1.2 Å for 129 Ca). Similarly, all
31 PmScsC protomers share the same trimeric right-handed
coiled coil stalk formed from the N-terminal residues (Fig. 3a–c).
At the secondary structure level, it is only the 11-residue linker
peptide that changes significantly across the crystal structures
(Fig. 4c, Supplementary Movie 1).
The linker is a shape-shifting peptide that can adopt helical,
strand or loop conformations. In the 24 protomers present in the
compact PmScsC crystal structure, the linker forms a loop that
positions the three catalytic domains close to the trimerization
stalk (Figs 3a and 4c). In the extended crystal structure the linker
is helical, rotating and translating the catalytic domain away from
the trimerization domain relative to the compact structure
(Figs 3c and 4c). In the transitional PmScsC crystal structure,
each of the two trimers incorporates protomers in three
conformations: compact, extended-like and intermediate
(Fig. 3b). The two compact protomer conformations of the
transitional structure are similar to those in the compact crystal
structure (RMSD 0.9–1.8 Å for 188 Ca). The two extended-like
protomer conformations of the transitional structure are similar
to the protomer in the extended crystal structure though they
bend at different points in the linker helix, giving rise to
somewhat different catalytic domain placements (Fig. 4c). The
two intermediate conformations in the transitional crystal
structure have a linker that forms a short b-strand, and positions
the catalytic domain directly above the trimerization stalk
(Fig. 4c).
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Figure 2 | SAXS and MALLS of PmScsC. (a) Small-angle X-ray scattering
data collected from wild type PmScsC (grey) and the calculated scattering
profile of the ensemble model overlayed in black (SASBDB: SASDB94). The
predicted scattering profile of each of the crystal structures is also shown
(dashed lines: PDB: 4XVW compact, red; PDB: 5IDR transitional, blue; PDB:
5ID4 extended, green). The agreement between the experimental data and
the ensemble model is excellent, yielding w2¼ 1.0 (compared to w2¼ 863.9
(compact); w2¼ 1222 (transitional); w2¼ 348.2 (extended)). The Guinier
region (inset) of the scattering data is linear, consistent with a
monodisperse solution. (b) Pair distance distribution function derived from
the scattering data, showing the maximum dimension of the particles in
solution is 105Å. Also shown is the calculated p(r) for each of the crystal
structures (dashed lines: compact, red; transitional, blue; extended, green),
showing a maximum dimension of 90, 105 and 100Å, respectively. The p(r)
generated from the extended structure (green) is most similar to the
experimentally derived p(r), while the other p(r) curves are markedly
different. (c) MALLS profile of PmScsC and PmScsCDN. PmScsC eluted
faster (21.5min) than PmScsCDN (27.2min): experimentally determined
molecular masses are 74±0.3 kDa for PmScsC (theoretical trimer mass
74.3 kDa) and 18.3±0.3 kDa for PmScsCDN (theoretical monomer mass
18.1 kDa).
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Figure 3 | PmScsC crystal structures. (a) Compact (PDB: 4XVW), (b) Transitional (PDB: 5IDR) and (c) Extended (PDB: 5ID4) crystal structures of
PmScsC. Upper panels: side view, secondary structure with catalytic domains in green, 11-residue peptide linker in cyan and trimerization domains in
magenta or white. Height in this orientation is indicated. In each case, one trimerization domain is shown in magenta for comparison of the conformational
changes across the three crystal structures. Lower panels: top view, surface representation (catalytic TRX fold domains green, trimerization domains
white), maximum dimension in this orientation is labelled. Active site positions are indicated in orange for each protomer.
Table 1 | PmScsC crystal structure statistics.
Compact (4XVW) Transitional (5IDR) Extended (5ID4)
Data collection
Space group P 21 I4 H32
Cell dimensions
a, b, c (Å) 137.5, 163.9, 181.9 193.1, 193.1, 105.8 86.7, 86.7, 330.9
a, b, g (deg) 90, 90, 90 90, 90, 90 90, 90, 120
Resolution (Å) 91.15–2.60 (2.74–2.60) 136.51–2.56 (2.57–2.56) 110.29–2.92 (2.93–2.92)
Rmerge 0.072 (0.617) 0.083 (0.741) 0.059 (0.625)
I/sI 11.0 (2.0) 14.9 (2.2) 14.2 (2.8)
Completeness (%) 98.6 (95.4) 99.4 (100.0) 99.2 (100.0)
Redundancy 3.8 (3.7) 4.1 (4.1) 4.1 (4.2)
Refinement
Resolution (Å) 91.15–2.60 42.82–2.56 40.36–2.92
No. reflections 243409 62069 10652
Rwork/Rfree (%) 24.8/28.2 17.1/22.2 25.1/26.3
No. atoms
Protein 40850 10262 1720
Ligand/ion NA NA NA
Water 281 82 0
B factors (Å2)
Protein 59.7 50.6 122.2
Ligand/ion NA NA NA
Water 41.5 43.0 NA
RMS deviations
Bond length (Å) 0.006 0.008 0.010
Bond angles (deg) 1.21 1.05 1.17
Single crystals were used to collect each data set. Values for the highest resolution shell are shown in parentheses.
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As a consequence of the linker peptide flexibility, the three
crystal structures describe extraordinarily different PmScsC
quaternary shapes and dimensions. The eight compact PmScsC
trimers are mushroom-shaped with dimensions 80 80 50Å3
(Fig. 3a). The two intermediate PmScsC crystal structures are
asymmetric flat triangles with dimensions 105 40 70Å3
(Fig. 3b). The extended PmScsC crystal structure is three-leaf-
clover shaped with dimensions 75 80 80Å3 (Fig. 3c).
We hypothesized that the dynamic motion suggested by the
crystal structures, and supported by solution data, is critical to the
mechanism of PmScsC. Indeed, replacement of the shape-shifting
peptide with a rigid helical peptide (PmScsC RHP,
39-AEAAAKEAAAKA-50)12 reduced the flexibility of the
protein as evidenced by small angle scattering data
(Supplementary Fig. 7), and abolished activity in the isomerase
assay (Fig. 1c). Furthermore, we showed that trimerization of
PmScsC is critical for activity because removal of the N-terminal
residues (PmScsCDN) also abolishes in vitro disulfide isomerase
activity (Fig. 1c) and in vivo complementation assays (swarming
in the presence of copper) (Fig. 1b).
Curiously, Nature has also performed the ScsCDN experiment.
PmScsC shares 58% sequence identity with Salmonella enterica
serovar Typhimurium StScsC13 (Supplementary Fig. 8) and both
proteins contribute to copper resistance. Whereas we showed
above that PmScsC is required for swarming motility under
copper stress, StScsC is required for growth of S. Typhimurium in
rich media in the presence of copper. By contrast, deletion of scsC
in P. mirabilis had no effect on growth in rich media whether
copper was present or absent (Supplementary Fig. 2c). These
findings imply that the two proteins have different target
substrates and/or different molecular functions. Indeed, StScsC
and PmScsC are very different proteins. StScsC lacks the
N-terminal residues of PmScsC, it is monomeric rather than
trimeric, and it has no isomerase activity. Intriguingly, the
catalytic domains of the two proteins (as assessed by crystal
structures) are very similar (PDB: 4GXZ) (RMSD 1.0–1.6 Å for
129 Ca). On the basis of this comparison, we predicted that
removal of the N-terminal trimerization residues from PmScsC
would not only convert the trimer into a monomer and abolish
isomerase activity, it might also convert the enzyme into a dithiol
oxidase. Indeed, we confirmed that this was the case
(Supplementary Fig. 1d).
These two proteins, trimeric disulfide isomerase PmScsC and
monomeric dithiol oxidase StScsC, are encoded in similar loci
and are both associated with copper resistance. Yet, they have
very different architectures, and different molecular and cellular
functions. To examine if the region encoding the N-terminal
extension of PmScsC is broadly conserved in P. mirabilis, the
scsC gene was PCR amplified from 25 randomly selected clinical
isolates and sequenced. We found that the PmscsC sequence was
conserved in all 25 isolates—including the region encoding the
trimerization domain and shape-shifting motif—except for a
single synonymous mutation in the signal sequence. This high
degree of conservation suggests a highly conserved functional
role. Caulobacter crescentus ScsC also has an extended
N-terminal region and is predicted to be dimeric14. Altogether
with our work, this suggests that the N-terminal region of
this protein is necessary for oligomerization and that there are
at least two very different molecular and functional classes of
ScsC.
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Figure 4 | PmScsC protomer structure. (a) Cartoon representation of the PmScsC catalytic domain (equivalent to a DsbA fold, green). Secondary
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N- and C- termini are also labelled.
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How does the trimeric and highly dynamic molecular
architecture of PmScsC compare with other structurally char-
acterized disulfide isomerases? Until this point, highly efficient
disulfide isomerases were thought to function through the
presence of two TRX domains (each with a CXXC active site)
that can simultaneously interact with two substrate cysteines15.
The two active sites of V-shaped DsbC and U-shaped PDI are
embedded within a dynamic framework that enable shuffling of
substrate disulfides16–19 (Fig. 5a,b). Trimeric PmScsC also has the
potential to interact with multiple substrate cysteines
simultaneously. However, the evidence presented here shows a
much more expansive range of motion than observed previously
for DsbC or PDI, as depicted in morphing movies
(Supplementary Movies 2–4) and static structural comparison
(Fig. 5c). For example, the distance between active sites of DsbC
(PDB: 1JZD-1EEJ)3,16 or PDI (PDB: 4EKZ-4EL1)18 in reported
crystal structures ranges between 31–39Å (26% increase) and
28–40Å (43%), respectively. By comparison, this distance ranges
from 16 to 52Å (225%) in PmScsC.
Discussion
Why is it that other characterized disulfide isomerases do not
have the highly flexible, trimeric structure of PmScsC? How does
the monomeric S. Typhimurium ScsC—not a disulfide
isomerase—confer copper resistance? How do the very diverse
ScsC proteins (monomeric, dimeric or trimeric) form redox relay
systems with a predicted partner protein ScsB14 that appears to be
highly conserved in bacterial Scs gene clusters? The likely
explanation for the diversity in architecture and flexibility of
ScsC proteins may relate to differences in their target specificity.
The structural diversity among ScsC homologues may simply
reflect the fact that each ScsC homologue has evolved to optimize
disulfide reduction and/or isomerization of a distinct protein
substrate or set of substrates that are sensitive to copper-induced
damage. Identifying and characterizing these specific substrates,
and understanding why these are not refolded or reduced by
other periplasmic TRX-fold proteins are key questions that will
inform our understanding of bacterial copper resistance
mechanisms.
In summary, PmScsC is a unique and highly dynamic disulfide
isomerase. The N-terminal residues bring three catalytic domains
together into a trimer, and a unique flexible linker enables
extraordinary twisting and extending motions that impact on the
catalytic domain placement. Crystal structure snapshots sup-
ported by X-ray scattering data from solution, indicate an almost
doubling in length of the protein in one dimension, in concert
with considerable catalytic domain rotation. The combination,
extent and diversity of these motions would enable mis-folded
substrates bound to PmScsC to explore a broad folding landscape,
consistent with the redox foldase activity of this key P. mirabilis
copper resistance protein. These findings show in much greater
detail than ever before how redox proteins with multiple active
sites are able to shuffle incorrectly folded substrates. It is unclear
whether PmScsC directly interacts with copper or how it interacts
with other proteins required for virulence under copper stress.
Nevertheless, the structural data may provide a suitable basis for
drug discovery targeting a central defence mechanism of an
important human pathogen20,21. Importantly, the shape-shifting
motif may also represent a modular component for dynamic
motion that could be used in ‘plug and play’ protein engineering
applications.
Methods
Bacterial strains and growth conditions. BLAST searches of DsbA homologues
were performed on the genome of Proteus mirabilis HI4320 (ref. 22). Clinical
isolates of P. mirabilis were cultured from the urine or blood of patients with
urinary tract infection or bacteremia. The isolates were sourced from the Princess
Alexandra Hospital or Sullivan Nicolaides Pathology (Brisbane, Australia). E. coli
Top10 (Invitrogen) was used for plasmid manipulations. E. coli and P. mirabilis
were cultured in Luria-Bertani (LB) broth (10 g l 1 tryptone, 5 g l 1 yeast extract,
10 g l 1 NaCl) on LB agar (LB medium containing 15 g l 1 agar). To prevent
swarming of P. mirabilis, LB medium containing 30 g l 1 agar and without NaCl
was used. Media were supplemented with chloramphenicol (30 mgml 1),
ampicillin (100 mgml 1) or kanamycin (25mgml 1) as required.
Construction of Proteus mirabilis scsC mutants. Mutation of the scsC gene in
P. mirabilis PM38 and PM54 was performed using the TargeTron gene knockout
system (Sigma-Aldrich) as per the manufacturer’s instructions. Briefly, optimal
intron insertion sites and primer sequences (5827, 50-aaaaaagcttataattatc cttaag-
tatcgaagatgtgcgcccagatagggtg, 5828, 50-cagattgtacaaatgtggtgataacagataagtcgaa-
gatgctaacttacctttctttgt, 5829, 50-tgaacgcaagtttctaatttcgattatacttcgatagagg aaagtgtct)
were predicted using the Sigma TargeTron online algorithm, followed by a retar-
geting PCR and cloning of the amplicon into the pACD4-K-C shuttle vector,
resulting in the generation of plasmid pACD4-K-CscsC. Plasmid pAC4K-CscsC
and pAR1219 (helper plasmid) were transformed into PM38 and PM54; induction
and retargeting of the intron containing the kanamycin-resistance gene cassette
into scsC was performed according to the manufacturer’s instructions. Transfor-
mants with the correct intron insertion were selected by growth in the presence of
kanamycin. Mutants with the correct insertion were confirmed by PCR and
nucleotide sequencing using primers 5914 (50-atgaaaaaaatttggctggcgttagc) and 5915
(50-ttattttttcatcagtaattgattgacgacatcagaataag), and referred to as PM38scsC and
PM54scsC, respectively. The reprogrammed intron was inserted between nucleo-
tide 528 and 529 in the sense strand of scsC. Plasmids pACD4-K-CscsC and
pAR1219 were cured by passaging on nonselective medium followed by screening
for loss of chloramphenicol and ampicillin resistance. Plasmid pScsC was con-
structed by amplifying the scsC gene from PM54 using primers PMscsC-pSU2718F
(50- gcgtctagattaactattctttcagaggctaaaggagcc) and PMscsCpSU2718R (50-
cgaagcttcgttattttttcactttcgccagttgttctttcac), digestion with XbaI-HindIII and ligation
into XbaI-HindIII digested pSU2718. Mutation of the CXXC active site (C82A;
plasmid pScsC AXXC) and deletion of residues 1–42 (plasmid pScsCDN) was
performed by PCR; all constructs were confirmed by sequencing. These mutants
retained the periplasmic signal sequence. Complementation was performed by
hPDI
EcDsbC 
a 
b 
c 
PmScsC 
Top Side
Figure 5 | Disulfide isomerase range of motion. Top and side views of (a)
U-shaped human PDI with two catalytic domains (PDB: 4EKZ and 4EL1),
(b) V-shaped homodimeric EcDsbC with two catalytic domains (PDB: 1JZD
and 1EEJ) and (c) homotrimeric PmScsC (this work, PDB: 4XVW and 5ID4)
showing its expansive twisting and elongation motions. Catalytic domains
are shown in green, active sites (CXXC) in orange, and oligomerization or
non-catalytic domains in white. See also Supplementary Movie 1.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms16065
6 NATURE COMMUNICATIONS | 8:16065 | DOI: 10.1038/ncomms16065 | www.nature.com/naturecommunications
introducing plasmids pScsC, pScsC AXXC, pScsCDN or pSU2718 (vector control)
into PM54scsC.
Swarming motility in the presence of CuSO4. Overnight cultures of P. mirabilis
were diluted in fresh LB broth to an OD600 of 0.1. Swarming on LB agar was
examined in the absence or presence of CuSO4 (final concentration of 1.5mM). For
assays performed in the presence of CuSO4, a 10ml sample of the diluted
P. mirabilis PM54 and PM54scsC strains, respectively, was inoculated onto the
centre of an agar plate and allowed to soak into the agar (resulting in equal
diameter for each sample). The plates were incubated at 37 C. The diameter of the
swarming zone was measured after 14 h incubation, and every one or two hours
thereafter for a total of 10 h. Swarming of PM54scsC containing pSU2718 (vector
control) or complementation plasmids (pScsC, pScsC AXXC and pScsCDN) was
performed as described above, but with the addition of chloramphenicol
(30 mgml 1) and 1mM isopropyl b-D-1-thiogalactopyranoside for ScsC induc-
tion. Swarming motility at 37 C on LB agar was measured after 6 and 8 h of
incubation. Three replicate experiments were performed for all assays. Swarming
motility of PM38 wild-type, mutant and complemented strains in the presence and
absence of copper was performed in the same manner.
Western blotting. ScsC expression in P. mirabilis wild-type, mutant and com-
plemented strains was examined by western blot analysis. Crude cell lysates were
prepared from standardized overnight cultures. Samples were resolved by SDS–
polyacrylamide gel electrophoresis (SDS–PAGE) and transferred onto a poly-
vinylidene difluoride membrane. Blots were probed using a PmScsC specific
polyclonal antiserum raised in rabbits (WEHI Antibody Facility) at 1:1,000 dilution
in phosphate buffer saline with 0.05% v/v Tween-20.
Protein production. Codon-optimized PmScsC (see Supplementary Note 1 for the
sequence) lacking the first 21 amino acids (which correspond to the predicted
secretion signal) or PmScsCDN (lacking the first 63 residues, starting at A1Q2F3y)
was inserted into pMCSG7 (Midwest Center for Structural Genomics) by ligation-
independent cloning. PmScsC and PmScsCDN were expressed in BL21(DE3)pLysS
cells (Novagen) at 30 C for 16–20 h using ZYP-5052 autoinduction media23.
Selenomethionine-labelled PmScsC (mature PmScsC contains four native
methionine sites) was expressed in BL21(DE3)pLysS cells grown in minimal media
(M63) supplemented with 0.05mgml 1 D/L-selenomethionine. Recombinant
protein expression was induced by 0.1mM isopropyl b-D-1-thiogalactopyranoside
overnight at 30 C.
After expression, all cells were collected by centrifugation then resuspended in
lysis buffer (25mM Tris pH 7.4, 150mM NaCl) with added protease inhibitor
(1:1,000 dilution into lysate, BioPioneer, Inc., USA) and DNase I (3.3 mgml 1 final
concentration, Sigma-Aldrich). The bacterial cells were processed through a
Constant Systems (LTD, UK) TS-Series cell disruptor twice, at pressures of 22 and
24 kpsi. The lysate was clarified by centrifugation (40,000 g, 30min, 4 C, rotor
JA-25.5, Beckman Coulter, Brea, CA) and the soluble fraction was run twice over
2 3ml of equilibrated Talon (Clontech) resin to bind the His-tagged protein. The
resin was washed with six column volumes of lysis buffer before the protein was
eluted with 25mM Tris pH 7.4, 150mM NaCl, 250mM imidazole. To remove the
His6-tag, Tobacco Etch Virus (TEV) protease cleavage was performed at room
temperature for 2 h with 1mg of TEV protease per 50mg of His-tagged protein.
The protein mixture was then desalted using a Sephadex G-25 fine 16/60 column
connected to an A¨KTA FPLC system (GE Healthcare) and reverse IMAC (2 2ml
of Talon resin) was used to separate cleaved protein from the His-tagged
contaminants. PmScsC and PmScsCDN were reduced or oxidized with a 25-fold
molar excess of DTT, or a 10-fold molar excess of copper(II)/1,10-phenanthroline,
respectively. The final step of purification for the proteins was size-exclusion
chromatography using a Superdex S75 column with 10mM HEPES pH 7.4,
150mM NaCl. Proteins were concentrated using Amicon Ultra centrifugal filter
devices with a 10-kDa cutoff (Merck Millipore, USA). Yields for PmScsC were
B80 mg of purified protein per litre of culture. SDS–PAGE (NuPAGE 4–12%
BisTris gel, Invitrogen, Australia) with Coomassie blue stain was used to assess the
protein quality. Concentration of protein samples was determined using the A280 of
the sample (read using a Thermo Scientific NanoDrop 2000c spectrophotometer)
and calculated extinction coefficients from ProtParam24.
E. coli DsbA and E. coli DsbC, lacking the periplasmic leader signal were
expressed and purified, as described for PmScsC.
Design of PmScsC rigid helical peptide mutant. The 11-amino-acid flexible
linker peptide in PmScsC (residues 39-KADEQQAQFRQ-49) was replaced with a
12-amino-acid rigid helical peptide (39-AEAAAKEAAAKA-50)12 using overlap
extension PCR25 with the primers, 50-gcagaagcagcggccaaagaggctgcggctaaagccgca
ctggctagcgaacatgatgcc and 50- ggctttagccgcagcctctttggccgctgcttctgctttcgtctgcagagcca
tgattgc. The mutated gene was then reinserted into pMCSG7 by ligation-
independent cloning. The construct was confirmed by sequencing and the protein
expressed and purified, as described for wild-type PmScsC.
PmScsC sequence conservation. All clinical isolates were de-identified, and
individual informed consent was not required. Genomic DNA isolation was per-
formed using the UltraClean Microbial DNA Isolation Kit (MO-BIO Laboratories,
#12224) according to the manufacturer’s instructions. Yields varied between 100
and 500 ng ml 1 of DNA. PCR amplification of the scsC gene from P. mirabilis
strains was performed using a sequence specific primer pair (50-gtgccgttt aacca-
gatttatg) and (50-cgtagataaatcagtaagttctg) in combination with Phusion High-
Fidelity DNA Polymerase (New England BioLabs Inc., MA, USA). DNA was
initially denatured in a single step at 98 C for 30 s followed by 30 cycles of
denaturation (98 C, 10 s), annealing (50 C, 20 s) and elongation (72 C, 30 s). In a
final step fragment elongation was completed at 72 C for 7min. PCR samples were
examined by electrophoresis and subsequent DNA sequencing.
Chemical cross-linking. In total 150 mM of purified PmScsC (in 50mM HEPES
buffer pH 8.5) was reacted with 3mM homobifunctional dithiobis(sulfosuccini-
midylpropionate) (DTSSP) (Pierce) for different time intervals (30 s–30min) at
23 C. DTSSP contains one amine-reactive N-hydroxysulfosuccinimide (sulfo-
NHS) ester at each end of its eight carbon spacer arm. The sulfo-NHS group reacts
preferentially with amines (from lysine residues) between pH¼ 7 and 9, to form a
stable amide bond. DTSSP contains a disulfide bond in the spacer arm, which can
be readily cleaved with dithiothreitol (DTT). Aliquots were removed at various
time points and mixed with (NH4)HCO3 (50mM final), to stop the reaction,
through hydrolysis of remaining functional ester groups in DTSSP. The samples
were then run on a non-reducing SDS–PAGE and subjected to Coomassie staining.
As control, 50mM DTT was added to selected samples, which led to cleavage of the
internal disulfide bond in DTSSP, and consequently disruption of cross-links
between ScsC protomers.
MALLS. A combined approach, using analytical size exclusion chromatography
(SEC) and multiangle laser light scattering (MALLS) was utilized to determine and
compare the stoichiometry of PmScsC with PmScsCDN in solution. The setting
consisted of an LC20 high-performance liquid chromatography (HPLC) system
(Shimadzu, Rydalmere, Australia) and a DAWN HELEOS II laser light detector
connected to an Optilab T-rEX refractive index detector (Wyatt Technology,
Dernbach, Germany). Either a Superdex 200 or Superdex 75 10/300 GL analytical
column (GE Healthcare, USA) was connected to the LC20 HPLC system and
equilibrated with 25mM Tris and 150mM NaCl, pH 7.5 overnight. Purified pro-
teins were injected (500 ml of 3mgml 1 at a flow rate of 1.0mlmin 1) into the
SEC-MALLS system for analysis. To calibrate the detector, 500ml of 5mgml 1
bovine serum albumin (BSA) (Sigma-Aldrich, Australia) was used in 25mM Tris
and 150mM NaCl, pH 7.5 at a flow rate of 1.0mlmin 1. Wyatt Astra V software
was used for data collection and analysis.
SAXS. Small angle X-ray scattering data were collected on the SAXS-WAXS
beamline at the Australian Synchrotron26. Immediately before loading, all samples
were centrifuged at 10,000 g to remove large particles from the solution, and
radiation damage was minimized by flowing samples (B100 ml) past the beam in
1.5mm quartz capillaries (Hampton Research). Data reduction was carried out
using the Australian Synchrotron Scatterbrain software27 correcting for sample
transmission and solvent scattering.
Scattering data were collected on reduced PmScsC wildtype and RHP mutant
proteins in 25mM HEPES pH 7.5, 150mM NaCl, 1mM DTT. Data were also
collected on oxidized wildtype PmScsC, but as no significant differences in the
scattering were observed, only data from the reduced forms are presented. To
confirm that the pH and ionic strength of the crystallization conditions do not
induce conformational changes in PmScsC, scattering data were collected from
wildtype PmScsC prepared at 0.50mgml 1 in a gradient of 25mM HEPES pH
(6.0, 6.5, 7.0, 7.5 and 8.0) and NaCl (150, 300, 600, 900 and 1,500mM). No
significant systematic change in the structural parameters was observed at any
point of the gradient, hence, it was concluded that neither ionic strength nor pH
influence the conformation of the complex in the ranges measured.
Data quality was assessed by inspection of the linearity of the Guinier region of
the data (qRgo1.3), estimated molecular mass of the protein complex, and
concentration dependence of the scattering. The estimated molecular mass was
determined as outlined in28, where the contrast and partial specific volume were
estimated from the protein sequence29. The pair-distance distribution function
(p(r)) was generated from the experimental data using GNOM30 from which I(0),
Rg and Dmax were determined. Rigid body modelling of the scattering data from
PmScsC wildtype and mutant proteins was performed using CORAL31. C3
symmetry was assumed, and the starting model was oriented such the 3-fold axis
was parallel with the z-axis, and passed through the centre of the oligomization
domain. Two rigid bodies were then defined for each monomer: residues 3–44
(oligomerization domain); 47–224 (catalytic domain). The position of the
oligomerization domain was fixed, and the position and orientation of the catalytic
domain was then optimized against the measured scattering data. The program was
run 16 times for each protein, but the models with the lowest penalty function still
showed small systematic deviations from the experimental data (Wildtype:
w2¼ 3.4; CorMap test32, 182 points, C¼ 51, P¼ 0.000; RHP mutant: w2¼ 5.6;
CorMap test, 171 points, C¼ 28, P¼ 0.000). Given the crystal structures show
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significant structural diversity, it is likely that these systematic deviations arise from
the fact that there is an ensemble of structures present in solution. Hence, ensemble
optimization was also performed with the program EOM33. From an initial pool of
1,000 structures (the oligomerization domain possessed C3 symmetry in all
structures, but the entire trimer was permitted to adopt either C1 or C3 symmetry),
a final ensemble of 6 structures was obtained that yielded an excellent fit to the data
(Wildtype: w2¼ 1.0; CorMap test, 182 points, C¼ 12, P¼ 0.021; Mutant: w2¼ 1.8;
CorMap test, 171 points, C¼ 11, P¼ 0.076). The ensemble for the wildtype protein
is composed of six structures and spans a diverse range of conformations. Thus, the
SAXS data supports the notion that the PmScsC trimer is highly dynamic in
solution. The ensemble for the mutant protein is composed of four structures, all in
extended conformations. The initial pool of random structures was the same for
both WT and RHP optimizations, and the number of structures in the final
ensemble was not artificially limited. The reduction in size of the ensemble (from 6
for WT to 4 for RHP) is consistent with the RHP mutation rigidifying the flexible
helix, and reducing the conformational space sampled by the protein. Details of the
data collection and structural parameters are summarized in Supplementary
Table 1.
Crystallization and structure determination. Crystallization screenings were
performed at the UQ ROCX facility at the University of Queensland (uqrocx.im-
b.uq.edu.au) using commercial screens and the hanging-drop vapour diffusion
method.
Compact structure. Selenomethionine-labelled PmScsC crystals were grown at
20 C from a drop comprising 200 nl of 30mgml 1 purified protein in 10mM
HEPES pH 7.4 and 200 nl of well solution, 2.85M sodium malonate pH 5.8
containing 0.1M cobalt(II)chloride hexahydrate. Crystals grew over a period of 2–3
days. A data set at the Se-edge (wavelength¼ 0.9792Å) was measured under
cryogenic conditions (100 K) at the Australian Synchrotron MX2 beamline using
the BluIce interface34. Data were processed in XDS35 and scaled to space group
P21212 in AIMLESS36. A manually guided molecular replacement approach was
performed using StScsC as the template (PDB ID: 4GXZ) in MOLREP37. Manual
selection of solutions based on observed packing, allowed placing of six molecules
in the asymmetric unit. This solution was improved in the subsequent MR runs in
MOLREP37, allowing the addition of eight molecules in the second trial and a total
of nine molecules in the third run. A SAD-MR approach in PHENIX38, by
combining SAD phasing and the partial MR solution (nine molecules), and
subsequent density modifications resulted in an electron density map with a skew
value of 0.82 (1,826 residues (190 side chain built) in 250 fragments). Successive
AutoBuild runs in PHENIX38 built 1,557 residues (806 side chain) and dropped the
R and Rfree values to 38% and 41.5%, respectively. Extensive manual building was
required to complete one copy of PmScsC. Molecular replacement using this model
as template in PHASER39 allowed placing of 12 molecules in the asymmetric unit.
After several rounds of manual building in Coot40 and PHENIX38 refinements R/
Rfree values dropped to 29.1 and 32.3%, but further refinement cycles were
unsuccessful. Careful examination of Ctruncate41 indicated the presence of nearly
perfect pseudo-merohedral twinning (-h,-k,l) and led to a reconsideration of space
group. Reprocessing the data set to a resolution of 2.6 Å in space group P21 yielded
lower R-merge (0.072 versus 0.097 for data processed in P21212). A new molecular
replacement run using the reprocessed data in P21 space group and the PmScsC
template with a resolution cutoff set to 3.2 Å finally identified 24 copies in
PHASER39. Rigid body refinement in REFMAC42 showed that refinement
considering the twin operator (-h,-k,l) produced better R-factors (37 versus 42%,
no twinning). After manual correction of two chains that were placed inaccurately
during molecular replacement by PHASER39, and several rounds of refinement in
PHENIX38 and REFMAC42 the final R/Rfree values are 24.8/28.2% at 2.6 Å
resolution. The Ramachandran favoured/outlier statistics for the structure are
95%/0.9%. A stereo image of representative electron density for this structure is
show in Supplementary Fig. 9a.
Transitional structure. Crystals were grown at 20 C from drops containing 1 ml
of 48mgml 1 oxidized PmScsC in 10mM HEPES pH 7.4 and 1 ml of 2.85M
sodium malonate pH 5.8 containing 0.1M copper (II) chloride. Crystals formed
after 2–3 days and were cryoprotected with 3.4M sodium malonate pH 5.8 and
flash frozen in liquid nitrogen. Data were collected using the BluIce software34 on
the MX2 beamline of the Australian Synchrotron at a wavelength of 0.9792Å
under cryogenic conditions (100 K). The data were processed with XDS35 and
scaled in AIMLESS36 using the autoPROC framework43. The space group was
determined to be I4 and molecular replacement using PHASER39, as implemented
in the CCP4 suite44, was performed with a single catalytic domain from the
compact structure (residues 46–224). Five molecules were initially found in the
asymmetric unit and after assessing the crystal packing one of these was deleted
and a subsequent round of PHASER39 was run with the altered solution as an
additional input model. This resulted in the placement of 6 molecules in the
asymmetric unit, which is consistent with the presence of two trimers. Manual
building of the trimerization domain was performed in Coot and rounds of
autobuild using Buccaneer45 in CCP4 and refinement using REFMAC42 and
BUSTER46,47 were performed to improve the structure. Several rounds of manual
adjustment in Coot40 and refinement in PHENIX38 were performed to yield final
R/Rfree values of 17.1 and 22.2%. Validation in MolProbity48 was used throughout
the refinement process, and the final Ramachandran favoured/outlier statistics for
the structure are 98%/0.5%. A stereo image of representative electron density for
this structure is show in Supplementary Fig. 9b.
Extended structure. Crystals were grown at 20 C from drops containing 1 ml of
20mgml 1 oxidized PmScsC in 10mM HEPES pH 7.4, 150mM NaCl and
2.5mM copper (II) chloride (added to protein solution immediately before
crystallization) and 1 ml of 32% Jeffamine M-600 pH 7 in 0.1M HEPES pH 8.
Crystal formation occurred within minutes of set up and crystals continued to grow
until day two. Crystals were cryoprotected with 32% Jeffamine M-600 pH 7, 0.1M
HEPES pH 8 and 20% ethylene glycol and frozen in liquid nitrogen. Data were
collected using the BluIce software34 on the MX2 beamline of the Australian
Synchrotron at a wavelength of 0.9537Å under cryogenic conditions (100 K).
Using the autoPROC framework43 the data were processed with XDS35 and scaled
in AIMLESS36. The Wilson B factor for the data was relatively high (Bdouble that
of the data for the other two crystal structures). The space group was determined to
be H32 and molecular replacement using PHASER39, as implemented in the CCP4
suite44, was performed with a single catalytic domain from the compact structure
(residues 46–224). Only one molecule was found in the asymmetric unit (the trimer
is generated by crystal symmetry). Manual building of the trimerization domain
was performed in Coot with rounds of autobuild (Buccaneer45) and refinement
(BUSTER47) performed to improve the structure. Several rounds of manual
adjustment in Coot40 and refinement in PHENIX38, including the use of TLS, were
performed to yield final R/Rfree values of 25.1 and 26.3%. Validation in
MolProbity48 was used throughout the refinement process and the final
Ramachandran favoured/outlier statistics for the structure are 98%/0.5%. A stereo
image of representative electron density for this structure is show in Supplementary
Fig. 9c.
Residues in all three crystal structures were numbered based on their position
after the TEV cleavage site in the construct. MUSTANG-MR49,50 was used for
structure alignment and RMSD calculations and PyMOL was used to create images
of the structures and perform other measurements. The distance range between
active sites in DsbC, PDI and PmScsC structures was measured using the Cb
positions of the more N-terminal of the two catalytic cysteines. Supplementary
Movie 1 was created in Pymol by generating morphs between each of the PmScsC
crystal structures, as well as morphs between each of the available structures for
E. coli DsbC (PDB: 1JZD-1EEJ) and human PDI (PDB: 4EKZ-4EL1).
Measurement of PmScsC redox potential and pKa values. The redox potential
of PmScsC was determined by incubating 2 mM PmScsC with 1mM GSSG in
combination with varying concentrations of GSH (4–15mM) forB12 h at 24 C in
100mM sodium phosphate buffer, pH 7.0 and 1mm EDTA. Trichloroacetic acid,
10% v/v, was used to precipitate the protein samples and the pellets were washed
with ice-cold acetone. The samples were then treated with 2mM 4-acetamido-40-
maleimidylstilbene-2,20-disulfonic acid, in 50mM Tris–HCl, pH 8.0, and 1% SDS,
which blocks free thiols and increases the weight of the reduced protein by
B1 kDa. The reduced and oxidized forms of PmScsC were separated on a 12%
non-reducing SDS–PAGE (NuPAGE) and stained with Coomassie Brilliant Blue.
The fraction of reduced protein, R, was determined via densitometric analysis of
the stained SDS–PAGE gel using ImageJ51, and the equilibrium constant Keq was
calculated via R¼ ([GSH]2/[GSSH])/(Keqþ ([GSH]2/[GSSH]))52. The Nernst
equation, E0¼ E0GSH/GSSG–(RT/nF)  lnKeq, where E0GSH/GSSG is the standard
potential of  240mV (ref. 53), was used to calculate the redox potential of
PmScsC.
The pH-dependent absorbance of the catalytic thiolate anion of PmScsC was
determined at 240 nm (ref. 54) using a CARY 50 UV/VIS spectrophotometer
(Agilent Technologies, USA). The pH titration measurements of oxidized or
reduced PmScsC (40 mM) were conducted at 22 C in 2ml reaction buffer (10mM
Tris, 10mM sodium citrate, 10mM K2HPO4, 10mM KH2PO4, 200mM KCl and
1mM EDTA). Absorbance (l¼ 240 and 280 nm) was measured between pH 6.5
and 1.5 in 0.25 increments. The pKa value was calculated from the fitted curves of
three replicates using the Henderson–Hasselbalch equation (pH¼ pKa log
((A240/A280)red/(A240/A280)oxid)). Redox potential and pKa experiments were
each repeated three times.
Relative stability of oxidized and reduced PmScsCDN. Unfolding of
PmScsCDN was monitored using the change in the far-ultraviolet circular
dichroism (CD) signal55. The largest difference in molar ellipticity for oxidized and
reduced enzymes was calculated from initial far-ultraviolet CD spectra (from 250
to 190 nm) recorded at 25 and 95 C using a Jasco J-810 circular dichroism (CD)
spectropolarimeter (Jasco, USA), respectively. The unfolding of oxidized and
reduced protein (PmScsCDNox¼ 222.5 nm, PmScsCDNred¼ 219.5 nm) was
monitored at a constant heat rate of 1 Cmin 1 starting from 25 C and increasing
to 95 C in a 1mm quartz cuvette. Unfolding reactions were performed using
10 mM protein in 100mM NaH2PO4/Na2HPO4, 1mM EDTA at pH 7.0. Reduced
enzyme samples contained 0.75mM DTT. The CD data were converted to a
fraction of folded protein via afolded(T)¼ (y(T) yunfolded)/(yfolded yunfolded) and
afolded(T) was then fitted using a Boltzmann sigmoid function 1–1/(1þ eN(TmT)),
where N is a scaling factor that describes the nature of the transition and Tm is the
protein melting temperature. The thermal unfolding experiment was repeated three
times for both the oxidized and reduced protein.
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Protein disulfide isomerase assay. The bovine pancreatic ribonuclease RNase A
contains four disulfide bonds that are necessary for its enzymatic function. Starting
with ‘scrambled’ RNase A (in which the cysteines have formed non-native disulfide
bonds), one can determine the ability of other enzymes to restore its function by
spectroscopically monitoring the hydrolysis of 30 ,-50-cyclic monophosphate
(cCMP), a synthetic substrate of the ribonuclease. Thus, in vitro disulfide isomerase
activity of PmScsC was monitored by using scrambled RNase A as substrate56.
Inactive scrambled RNase A was produced by treating 70mg of native RNase A
(Sigma-Aldrich) with 6M guanidinium chloride and 150mM DTT in 50mM Tris
pH 8, incubated at room temperature for 16 h. After adjusting the solution to pH 8,
the unfolded protein was then desalted and buffer exchanged into 100mM acetic
acid/NaOH pH 4. The presence of reduced cysteines was confirmed
spectrophotometrically by mixing an unfolded RNase A sample with eight-fold
higher molar concentration of 5,5-dithio-bis-(2-nitrobenzoic acid) (DTNB or
Ellman’s reagent), which reacts with thiols to absorb at 412 nm. The unfolded
RNase A was then air-oxidized over 5 days in 6M guanidinium chloride, 50mM
Tris pH 8.5 at room temperature in the dark. After concentration of the protein
and readjustment of the pH to 8.5, the scrambled RNase A was buffer exchanged
into 100mM acetic acid/NaOH pH 4 and concentrated to 11.5mgml 1 for use in
assays. The absence of reduced cysteines was confirmed, as described above. The
total reaction volume for the scrambled RNase A assay was 750ml containing
100mM sodium phosphate buffer pH 7.0, 1mM EDTA, 8.2 mM DTT and 10 mM
PmScsC, PmScsCDN, PmScsC RHP, EcDsbC or EcDsbA and 40 mM of scrambled
RNase A. At various time intervals, 50 ml sample was removed and mixed with
150ml of 3mM cytidine 30 ,-50-cyclic monophosphate (cCMP) to measure RNase A
activity. Hydrolysis of the cyclic phosphate ester bond in cCMP was monitored at
296 nm using a Synergy H1 multimode plate reader (BioTek, USA). Samples
containing native RNase A and scrambled RNase A in the absence of any other
enzyme served as positive and negative controls, respectively. The disulfide
isomerase assays were repeated twice for each protein.
PmScsC dithiol oxidation activity. The potential of PmScsC/PmScsCDN to cat-
alyse disulfide bond formation in vitro was assessed using a synthetic model
peptide (CQQGFDGTQNSCK), as described before57. Dithiol oxidation was
determined fluorometrically, using a Synergy H1 multimode plate reader (BioTek
Instruments, USA) with the excitation wavelength set to 340 nm and emission to
615 nm. A 150ms delay before reading and 100 ms reading time were used for time-
resolved fluorescence. The reaction buffer contained 50mM MES, 50mM NaCl
and 2mM EDTA at pH 5.5. The reaction volume was 50 ml in each well of a white
384-well plate (Perkin Elmer OptiPlate-384, Part #: 6007290), including increasing
concentrations (80–320 nM) of EcDsbA, EcDsbC, PmScsC or PmScsCDN and
2mM glutathione (GSSG) as oxidant. At last, 8 mM peptide substrate was added to
initiate the reaction. EcDsbA served as positive control. As negative control,
reactions in the absence of proteins were used. The initial linear portion of the raw
data was used to calculate the rate of oxidation as fluorescence increase per minute.
The dithiol oxidation activity experiments were repeated three times for each
protein.
Data availability. The UniProt accession code for the P. mirabilus ScsC protein
described in this paper is C2LPE2 and the accession codes for other proteins
described in this study are H9L4C1 (StScsC), P0AEG4 (EcDsbA) and P0AEG6
(EcDsbC). Coordinates and structure factors for the three ScsC crystal structures
were deposited in the protein data bank (PDB) with accession codes 4XVW
(compact), 5IDR (transitional) and 5ID4 (extended). In addition to the PDB
accession codes listed above, PDB accession code 4GXZ (StScsC) was used as a
molecular replacement template and 1EEJ and 1JZD (EcDsbC), and 4EKZ and
4EL1 (hPDI) were used to generate Fig. 5. Scattering data and models have been
deposited in SASBDB58 with accession codes SASDB94 (wildtype PmScsC) and
SASDBW6 (RHP mutant). All other data are available from the corresponding
authors upon reasonable request.
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